|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-5-2
|
|
pubmed:abstractText |
It has been shown that incomplete blockade of platelet reactivity is a risk factor for future ischemic events in patients with cardiovascular diseases. Despite these findings, there is yet no gold standard of platelet reactivity estimation. The 2 most commonly used methods in platelet testing are platelet aggregometry and vasodilator-stimulated phosphoprotein phosphorylation (VASP) assay. They both showed the predictive value for future adverse events in cardiac patients; however, there are few data that compare these 2 methods.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Monophosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Microfilament Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/P2RY12 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P2Y Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2Y12,
http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine,
http://linkedlifedata.com/resource/pubmed/chemical/cangrelor,
http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel,
http://linkedlifedata.com/resource/pubmed/chemical/vasodilator-stimulated...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1897-9483
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-21
|
|
pubmed:meshHeading |
pubmed-meshheading:21532533-Adenosine Monophosphate,
pubmed-meshheading:21532533-Adult,
pubmed-meshheading:21532533-Aged,
pubmed-meshheading:21532533-Cell Adhesion Molecules,
pubmed-meshheading:21532533-Female,
pubmed-meshheading:21532533-Flow Cytometry,
pubmed-meshheading:21532533-Humans,
pubmed-meshheading:21532533-Male,
pubmed-meshheading:21532533-Microfilament Proteins,
pubmed-meshheading:21532533-Middle Aged,
pubmed-meshheading:21532533-Phosphoproteins,
pubmed-meshheading:21532533-Platelet Aggregation,
pubmed-meshheading:21532533-Platelet Function Tests,
pubmed-meshheading:21532533-Predictive Value of Tests,
pubmed-meshheading:21532533-Purinergic P2Y Receptor Antagonists,
pubmed-meshheading:21532533-Receptors, Purinergic P2Y12,
pubmed-meshheading:21532533-Ticlopidine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockade.
|
|
pubmed:affiliation |
Silesian Center for Heart Diseases, ul. Szpitalna 2, Zabrze, Poland. wkuliczkowski@wp.pl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
